Market Report, "Slovenia Pharmaceuticals & Healthcare Report Q4 2014", Published
Slovenia is facing deflationary pressures on cons umer prices , which will impact pharmaceutical spending - especially as an increasing proportion of high - value drugs is met by co-payments. We have therefore downwardly revised our pharmaceutical forecast for 2014. A high budget deficit limits room for the new government to increase funding for health services, and we expect healthcare spending to decline this year and next, before returning to modest growth in 2016.
View full press release